You are here

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
San Bernardino, California, United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Schizophrenia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients newly treated for schizophrenia and those receiving continuing treatment will
be eligible if the treating psychiatrist is ready to initiate a new antipsychotic
medication, and would consider using either ziprasidone or olanzapine as an
appropriate therapy.

- Male and female patients who meet all criteria listed below are eligible to be
enrolled in this study:

- Diagnosed with schizophrenia

- Willing to provide information on at least one alternate contact person for study
staff to contact regarding patient's whereabouts, should the patient be
lost-to-follow-up over the course of the study

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Progressive fatal disease of a life expectancy which prohibits them from participating
in a one year research study

- Previously randomized to study medication and enrolled in this study

NCT00418171
Pfizer
Completed
Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now